Patient-reported outcomes to enhance person-centred HIV care.


Journal

The lancet. HIV
ISSN: 2352-3018
Titre abrégé: Lancet HIV
Pays: Netherlands
ID NLM: 101645355

Informations de publication

Date de publication:
01 2020
Historique:
received: 03 06 2019
revised: 27 08 2019
accepted: 29 08 2019
pubmed: 30 11 2019
medline: 23 7 2020
entrez: 29 11 2019
Statut: ppublish

Résumé

Quality of life has been proposed as the fourth 90 to complement the UNAIDS 90-90-90 targets to monitor the global HIV response, highlighting a need to address the holistic needs of people living with HIV beyond viral suppression. This proposal has instigated a wider discussion about the use of patient-reported outcomes (PROs) to improve the treatment and care of an ageing HIV population with increasing comorbidities and a disproportionate burden of social problems. PROs can provide a first-hand assessment of the impact of HIV treatment and care on patients' quality of life, including symptoms. The field of PRO measures is rapidly expanding but still no gold standard exists, raising concerns about tool selection. Challenges also remain in the collection, interpretation, and use of PRO data to improve the performance of the health system. An emerging concern is how to adapt PROs to different sociocultural and geographical settings.

Identifiants

pubmed: 31776101
pii: S2352-3018(19)30345-5
doi: 10.1016/S2352-3018(19)30345-5
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e59-e68

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Meaghan Kall (M)

HIV/STI Department, National Infection Service, Public Health England, London, UK. Electronic address: meaghan.kall@phe.gov.uk.

Fabienne Marcellin (F)

Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.

Richard Harding (R)

Florence Nightingale Faculty of Nursing, Midwifery, and Palliative Care, Cicely Saunders Institute, Kings College London, London, UK.

Jeffrey V Lazarus (JV)

Barcelona Institute for Global Health, Hospital Clínic, University of Barcelona, Barcelona, Spain.

Patrizia Carrieri (P)

Aix Marseille University, Institut National de la Santé et de la Recherche Médicale, Institution Française Publique de Recherche, Sciences Economiques et Sociales de la Santé et Traitement de l'Information Médicale, Marseille, France; Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH